Maaike G. Dijkstra

Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands

Maaike G. Dijkstra, Marjolein van Zummeren, Lawrence Rozendaal et al. · BMJ · 2016 · 116 citations · Full text

Primary hrHPV DNA Testing in Cervical Cancer Screening: How to Manage Screen-Positive Women? A POBASCAM Trial Substudy

Maaike G. Dijkstra, Dirk van Niekerk, Dorien Rijkaart et al. · Cancer Epidemiology Biomarkers & Prevention · 2013 · 91 citations · Full text

p16^INK4aimmunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions

Maaike G. Dijkstra, Daniëlle A.M. Heideman, Sabine C de Roy et al. · Journal of Clinical Pathology · 2010 · 80 citations

Comparing the performance of <i>FAM19A4</i> methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high‐risk HPV‐positive women of a gynecologic outpatient population (COMETH study)

Roosmarijn Luttmer, Lise M.A. De Strooper, Johannes Berkhof et al. · International Journal of Cancer · 2015 · 73 citations · Full text

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women

Roosmarijn Luttmer, Lise M.A. De Strooper, Maaike G. Dijkstra et al. · British Journal of Cancer · 2016 · 65 citations · Full text